Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Development and Validation of a Machine Learning-Based Early Warning System for Predicting Venous Thromboembolism Risk in Hospitalized Lymphoma Patients Undergoing Chemotherapy: A Multicentre, Retrospective Cohort Study

Tingting Jiang, Zailin Yang, Xinyi Tang, Yakun Zhang, Shuang Chen, Yu Peng, Xiaomei Zhang, Li Jun, Bingling Guo, Jieping Li, Tingting Liu, Haike Lei, Zuhai Hu, Na Fang, Xia Wei, Xuefen Liu, Yong Chen, Yao Liu

Blood (2024) 144 (Supplement 1): 1259.

https://doi.org/10.1182/blood-2024-206307

Published: 2024

Journal Articles

Nutritional and Immune-Inflammatory Scoring System for Predicting Prognosis in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Yu Peng, Tingting Jiang, Shuang Chen, Xinyi Tang, Yakun Zhang, Dan Ji, Liangmei Li, Longrong Ran, Li Jun, Nanjun Li, Zailin Yang, Yao Liu

Blood (2024) 144 (Supplement 1): 6463.

https://doi.org/10.1182/blood-2024-204285

Published: 2024

Journal Articles

The Disparity of Circulating Immune Cell Subsets and Inflammatory Status between HIV-Positive and HIV-Negative Patients with Lymphoma

Qing Xiao, Xi Quan, Shuang Chen, Chaoyu Wang, Li Jun, Xiaomei Zhang, Zailin Yang, Yao Liu

Blood (2024) 144 (Supplement 1): 6271.

https://doi.org/10.1182/blood-2024-204358

Published: 2024

Journal Articles

HIV-Related Diffuse Large B Cell Lymphoma Influences on T Cell Exhaustion

Tingting Jiang, Yu Peng, Xinyi Tang, Shuang Chen, Zailin Yang, Yao Liu

Blood (2023) 142 (Supplement 1): 3013.

https://doi.org/10.1182/blood-2023-182550

Published: 2023

Journal Articles

Predictive Modeling of Hematopoietic Stem Cell Mobilization and Collection Based on Peripheral Blood Marker

Longrong Ran, Yu Peng, Mingyu Zhao, Xin Luo, Shuang Chen, Zailin Yang, Yao Liu

Blood (2023) 142 (Supplement 1): 6948.

https://doi.org/10.1182/blood-2023-182643

Published: 2023

Journal Articles

Neutralizing Antibody Responses in Patients with Hematological Malignancies after Omicron Infection: A Multicenter, Prospective Cohort Study in China

Blood (2023) 142 (Supplement 1): 2557.

https://doi.org/10.1182/blood-2023-179113

Published: 2023

Journal Articles

Analysis of Influencing Factors of Positive Antiplatelet Antibody in Patients with Diffuse Large B-Cell Lymphoma

Wei Zhang, Longrong Ran, Mingyu Zhao, Yu Peng, Xin Luo, Shuang Chen, Zailin Yang, Yao Liu

Blood (2023) 142 (Supplement 1): 6300.

https://doi.org/10.1182/blood-2023-182666

Published: 2023

Journal Articles

Analysis of Fluorescence in Situ Hybridization Detection Results and Clinical Indicators in 51 Patients with Multiple Myeloma

Mingyu Zhao, Longrong Ran, Xin Luo, Lian Li, Yu Peng, Shuang Chen, Wei Zhang, Zailin Yang

Blood (2022) 140 (Supplement 1): 12551.

https://doi.org/10.1182/blood-2022-166581

Published: 2022

Journal Articles

Clinical Value of Gene Copy Number Variation Detection in Peripheral Blood in the Diagnosis and Treatment of Lymphoma

Shuang Chen, Lian Li, Xin Luo, Wei Zhang, Zailin Yang

Blood (2022) 140 (Supplement 1): 12129.

https://doi.org/10.1182/blood-2022-165759

Published: 2022

Journal Articles

The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR

Liang Zhou, Shuang Chen, Yu Zhang, Maciej Kmieciak, Yun Leng, Lihong Li, Hui Lin, Kathryn A. Rizzo, Catherine I. Dumur, Andrea Ferreira-Gonzalez, Mohamed Rahmani, Lawrence Povirk, Sri Chalasani, Allison J. Berger, Yun Dai, Steven Grant

Blood (2016) 127 (18): 2219–2230.

https://doi.org/10.1182/blood-2015-06-653717

Published: 2016

Includes: Supplemental data

Journal Articles

HDAC Inhibitors Reciprocally Interacts the Wee1 Inhibitor AZD1775 to Abrogate Both the G1/S and G2/M Checkpoints Via Chk1-Related cdc2/Cdk1 Threonine 14 Dephosphorylation in AML Cells

Yun Dai, MD PhD, Liang Zhou, MDPhD, Yu Zhang, PhD, Shuang Chen, MD PhD, Maciej Kmieciak, PhD, Yun Leng, MD, Lin Hui, MD, Steven Grant, MD

Blood (2014) 124 (21): 997.

https://doi.org/10.1182/blood.V124.21.997.997

Published: 2014

Journal Articles

A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis

Shuang Chen, Yu Zhang, Liang Zhou, Yun Leng, Hui Lin, Maciej Kmieciak, Xin-Yan Pei, Richard Jones, Robert Z. Orlowski, Yun Dai, Steven Grant

Blood (2014) 124 (17): 2687–2697.

https://doi.org/10.1182/blood-2014-03-564534

Published: 2014

Includes: Supplemental data

Journal Articles

Bim-Targeting Therapy Circumvents Adaptive Bortezomib-Resistance In Myeloma Through a Novel Cross-Link Between Autophagy and Apoptosis

Shuang Chen, MD/PhD, Yun Dai, MD, PhD, Yu Zhang, PhD, Liang Zhou, MD/PhD, Hui Lin, MD, Xin-Yan Pei, Robert Z. Orlowski, M.D., Ph.D., Steven Grant, MD

Blood (2013) 122 (21): 601.

https://doi.org/10.1182/blood.V122.21.601.601

Published: 2013

Journal Articles

Cytokinetically quiescent (G 0 /G 1 ) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2

Xin-Yan Pei, Yun Dai, Leena E. Youssefian, Shuang Chen, Wesley W. Bodie, Yukie Takabatake, Jessica Felthousen, Jorge A. Almenara, Lora B. Kramer, Paul Dent, Steven Grant

Blood (2011) 118 (19): 5189–5200.

https://doi.org/10.1182/blood-2011-02-339432

Published: 2011

Includes: Supplemental data

Journal Articles

Disruption of Src function potentiates Chk1-inhibitor–induced apoptosis in human multiple myeloma cells in vitro and in vivo

Yun Dai, Shuang Chen, Rena Shah, Xin-Yan Pei, Li Wang, Jorge A. Almenara, Lora B. Kramer, Paul Dent, Steven Grant

Blood (2011) 117 (6): 1947–1957.

https://doi.org/10.1182/blood-2010-06-291146

Published: 2011

Includes: Supplemental data

Journal Articles

Bortezomib Interacts Synergistically with Belinostat to Induce Apoptosis In Human Acute Myeloid and Lymphoid Leukemia Cells

Yun Dai, Shuang Chen, Li Wang, Xin-Yan Pei, Lora Kramer, Paul Dent, Steven Grant, MD

Blood (2010) 116 (21): 3266.

https://doi.org/10.1182/blood.V116.21.3266.3266

Published: 2010

Journal Articles

Targeting CDK9 Dramatically Potentiates ABT-737-Induced Apoptosis in Human Multiple Myeloma Cells through a Bim-Dependent Mechanism.

Yun Dai, MD, PhD., Shuang Chen, MD, PhD, Xin-Yan Pei, MD, Viswanathan Ramakrishnan, Ph.D, Michael Wang, MD, MS., Robert Orlowski, PhD, Paul Dent, PhD, Steven Grant, MD

Blood (2009) 114 (22): 297.

https://doi.org/10.1182/blood.V114.22.297.297

Published: 2009

Journal Articles

Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor–induced DNA damage in vitro and in vivo in human multiple myeloma cells

Yun Dai, Shuang Chen, Xin-Yan Pei, Jorge A. Almenara, Lora B. Kramer, Charis A. Venditti, Paul Dent, Steven Grant

Blood (2008) 112 (6): 2439–2449.

https://doi.org/10.1182/blood-2008-05-159392

Published: 2008

Includes: Supplemental data

Journal Articles

Vorinostat synergistically potentiates MK-0457 lethality in chronic myelogenous leukemia cells sensitive and resistant to imatinib mesylate

Yun Dai, Shuang Chen, Charis A. Venditti, Xin-Yan Pei, Tri K. Nguyen, Paul Dent, Steven Grant

Blood (2008) 112 (3): 793–804.

https://doi.org/10.1182/blood-2007-10-116376

Published: 2008

Includes: Supplemental data

Journal Articles

Vorinostat Synergistically Potentiates MK-0457 Lethality in Chronic Myelogenous Leukemia (CML) Cells Sensitive and Resistant to Imatinib Mesylate.

Yun Dai, PhD, Shuang Chen, PhD/MD, Charis A. Venditti, MD, Tri K. Nguyen, PhD, Paul Dent, PhD, Steven Grant, MD

Blood (2007) 110 (11): 1041.

https://doi.org/10.1182/blood.V110.11.1041.1041

Published: 2007

NARROW

Development and Validation of a Machine Learning-Based Early Warning System for Predicting Venous Thromboembolism Risk in Hospitalized Lymphoma Patients Undergoing Chemotherapy: A Multicentre, Retrospective Cohort Study

Nutritional and Immune-Inflammatory Scoring System for Predicting Prognosis in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

The Disparity of Circulating Immune Cell Subsets and Inflammatory Status between HIV-Positive and HIV-Negative Patients with Lymphoma

HIV-Related Diffuse Large B Cell Lymphoma Influences on T Cell Exhaustion

Predictive Modeling of Hematopoietic Stem Cell Mobilization and Collection Based on Peripheral Blood Marker

Neutralizing Antibody Responses in Patients with Hematological Malignancies after Omicron Infection: A Multicenter, Prospective Cohort Study in China

Analysis of Influencing Factors of Positive Antiplatelet Antibody in Patients with Diffuse Large B-Cell Lymphoma

Analysis of Fluorescence in Situ Hybridization Detection Results and Clinical Indicators in 51 Patients with Multiple Myeloma

Clinical Value of Gene Copy Number Variation Detection in Peripheral Blood in the Diagnosis and Treatment of Lymphoma

The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR

HDAC Inhibitors Reciprocally Interacts the Wee1 Inhibitor AZD1775 to Abrogate Both the G1/S and G2/M Checkpoints Via Chk1-Related cdc2/Cdk1 Threonine 14 Dephosphorylation in AML Cells

A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis

Bim-Targeting Therapy Circumvents Adaptive Bortezomib-Resistance In Myeloma Through a Novel Cross-Link Between Autophagy and Apoptosis

Cytokinetically quiescent (G 0 /G 1 ) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2

Disruption of Src function potentiates Chk1-inhibitor–induced apoptosis in human multiple myeloma cells in vitro and in vivo

Bortezomib Interacts Synergistically with Belinostat to Induce Apoptosis In Human Acute Myeloid and Lymphoid Leukemia Cells

Targeting CDK9 Dramatically Potentiates ABT-737-Induced Apoptosis in Human Multiple Myeloma Cells through a Bim-Dependent Mechanism.

Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor–induced DNA damage in vitro and in vivo in human multiple myeloma cells

Vorinostat synergistically potentiates MK-0457 lethality in chronic myelogenous leukemia cells sensitive and resistant to imatinib mesylate

Vorinostat Synergistically Potentiates MK-0457 Lethality in Chronic Myelogenous Leukemia (CML) Cells Sensitive and Resistant to Imatinib Mesylate.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only